WallStSmart
CERS

Cerus Corporation

NASDAQ: CERS · HEALTHCARE · MEDICAL DEVICES

$2.03
+5.73% today

Updated 2026-04-30

Market cap
$396.73M
P/E ratio
P/S ratio
1.93x
EPS (TTM)
$-0.08
Dividend yield
52W range
$1 – $3
Volume
1.7M

Cerus Corporation (CERS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-14.69M$-37.40M$-34.55M$-14.66M$-14.11M$-15.63M$-13.92M$-26.80M$-39.81M$-51.13M$-53.53M$-52.23M$-31.25M$-65.50M$-41.81M$-33.92M$-25.61M$-43.17M$11.36M$11.36M
Capital expenditures$1.11M$700000.00$1.19M$191000.00$1.71M$158000.00$81000.00$663000.00$2.11M$722000.00$563000.00$353000.00$1.14M$8.94M$1.61M$910000.00$2.00M$4.60M$2.84M$2.84M
Depreciation
Stock-based comp$2.60M$2.15M$2.05M$1.83M$1.85M$2.54M$3.27M$5.15M$6.73M$8.06M$9.36M$10.39M$13.31M$18.03M$23.57M$24.46M$20.27M$22.87M$22.87M
Free cash flow$-15.79M$-38.10M$-35.74M$-14.86M$-15.82M$-15.79M$-14.00M$-27.46M$-41.92M$-51.85M$-54.09M$-52.59M$-32.39M$-74.43M$-43.43M$-34.83M$-27.61M$-47.77M$8.52M$8.52M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.19M$10.50M
Share repurchases
Debt repayment
Net change in cash$-3.45M$1.20M$2.79M$-6.70M$48.24M$-48.89M$-8.81M$17.66M$5.83M$1.48M$13.06M$-12.96M